Target intelligence / Profile preview

Chromosome 6 open reading frame 163 (C6orf163)

Target
C6orf163
Molecular classification
Other (Uncharacterized protein; may be a regulatory or nuclear protein but not formally assigned to known families like receptor, enzyme, transporter, etc.)
01

Overview

Chromosome 6 open reading frame 163 (C6orf163) is a protein-coding gene in humans that encodes an uncharacterized protein of 329 amino acids, with the putative full-length protein having a molecular weight of approximately 38 kDa. Structural predictions indicate the presence of a long alpha helical region and a leucine zipper motif, which are typically associated with DNA-binding and regulatory roles in other proteins, such as transcription factors. C6orf163 is expressed at low levels in most tissues, with highest expression in testes and during early developmental stages (notably at 10 weeks of gestation), and expression declines later in development. It is localized to the nucleus and cytoplasm, suggesting possible regulatory function, but its exact biological activity and physiological role remain to be elucidated. C6orf163 is highly conserved across a wide range of animal species but has no identified paralogs in humans. While a physical interaction with the protein DRC6 (a component of the SCF-type E3 ubiquitin ligase complex involved in ciliary and flagellar function) has been reported, the biological consequence of this interaction is unknown. There are no described therapeutic agents, drug interactions, or known clinical implications for C6orf163 at this time.

Other names
C6orf163Chromosome 6 open reading frame 163Uncharacterized protein C6orf163
02

Mechanism of action

None established (no known mechanism of drug action described)

03

Biological functions

Other (Potential DNA-binding/regulatory role inferred from the presence of a leucine zipper motif, which is common in transcription factors; however, no confirmed functions have been reported)
04

Disease associations

Other (No well-established disease associations; nominal associations reported with very rare congenital neurodevelopmental disorders such as Pontocerebellar Hypoplasia, type 6 and Congenital Disorder of Glycosylation, type In; the mechanistic relationship is unclear and incidental in databases)

Beyond the preview

Go deeper on Chromosome 6 open reading frame 163 (C6orf163).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chromosome 6 open reading frame 163 (C6orf163).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call